Artigo · Revista · 2017

Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

C F Spraggs, L R Parham, L P Briley, Liling Warren, L S Williams, D J Fraser e mais 16

The Pharmacogenomics Journal

• Acesso fechado
• Com uma empresa
• Internacional · 8 países

Ir para a editora10.1038/tpj.2017.39